LHSW:NASDAQLianhe Sowell International Group Ltd Analysis
Data as of 2026-05-20 - not real-time
$0.22
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Lianhe Sowell International Group Ltd trades at a steep discount to its sector, with a trailing P/E of 7.46 versus an industry average of 38 and a price‑to‑book of 0.65. Revenue is expanding rapidly (≈57% YoY), yet operating margins are negative and profit margins hover just above 2%, indicating earnings fragility. The stock sits well below its 200‑day SMA (0.23 vs 1.13) and is hovering near the technical support of 0.158, while the MACD shows a bearish crossover and volume is on a downtrend, suggesting limited short‑term upside. High volatility (≈182% 30‑day) and a beta of 1.38 amplify price swings, and the company carries a massive debt‑to‑equity ratio of 20.2, underscoring balance‑sheet strain.
Given the extreme drawdown history (‑95% peak‑to‑trough) and a market cap of only $11.6 million, liquidity is thin and price moves can be abrupt. While the valuation metrics appear attractive, the combination of weak profitability, heavy leverage, and elevated risk factors makes the stock a speculative play rather than a stable investment.
Given the extreme drawdown history (‑95% peak‑to‑trough) and a market cap of only $11.6 million, liquidity is thin and price moves can be abrupt. While the valuation metrics appear attractive, the combination of weak profitability, heavy leverage, and elevated risk factors makes the stock a speculative play rather than a stable investment.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Bearish MACD histogram
- Decreasing volume trend
- Price near technical support
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong revenue growth but negative operating margin
- Undervalued relative to sector multiples
- High beta and volatility
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside if profitability improves
- Continued leverage concerns
- Thin market cap and liquidity constraints
Key Metrics & Analysis
Financial Health
Revenue Growth56.90%
Profit Margin2.48%
P/E Ratio7.5
ROE9.22%
ROA1.92%
Debt/Equity20.22
P/B Ratio0.6
Industry P/E38.0
Technical Analysis
TrendNeutral
RSI50.4
Support$0.16
Resistance$0.30
MA 20$0.23
MA 50$0.20
MA 200$1.13
MACDBearish
VolumeDecreasing
Fear & Greed Index89.02
Valuation
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.38
Volatility181.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.